Abstract
Chromium (VI) compounds are widely recognized as human carcinogens. Extensive studies in vitro and in model systems indicate that the reactive intermediate, Cr (V), generated by cellular reduction of Cr (VI), is likely the candidate for the ultimate carcinogenic form of chromium compounds. Here we review our current understanding of the in vivo reduction of Cr (VI) and its related free radical generation. Our results demonstrate that Cr (V) is indeed generated from the reduction of Cr (VI) in vivo, and that Cr (V) thus formed can mediate the generation of free radicals. Cr (V) and its related free radicals are very likely to be involved in the mechanism of Cr (VI)‐induced toxicity and carcinogenesis. These studies also illustrate that in vivo EPR spectroscopy and magnetic resonance imaging can be very useful and powerful tools for studying paramagnetic metal ions in chemical and biochemical reactions occurring in intact animals.
Similar content being viewed by others
References
Alcedo JA, Wetterhahn KE: Chromium toxicity and carcinogenesis. Int Rev Exp Pathol 31: 85–108, 1990
World Health Organization: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 49. Lyon, France, 1990
Bartlett RJ: Chromium cycling in soils and water: Links, gaps, and methods. Environ Health Perspect 92: 17–24, 1991
De Flora S, Serra D, Basso C, Zanacchi P: Mechanistic aspects of chromium carcinogenicity. Arch Toxicol 13(suppl): 28–39, 1989
Connett PH, Wetterhahn KE: Metabolism of the carcinogen chromate by cellular constituents. Struct Bonding 54: 93–124, 1983
Jennette KE: Microsomal reduction of the carcinogen chromate produces chromium (V). J Am Chem Soc 104: 874–875, 1982
Shi X, Dalal NS: Generation of hydroxyl radical by chromate in biologically relevant systems: Role of Cr (V) complexes vs. etraperoxochromate (V). Environ Health Perspect 102(suppl 3): 231–236, 1994
Shi X, Mao Y, Knapton AD, Ding M, Rojanasakul Y, Gannett PM, Dalal N, Liu K: Reaction of Cr (VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: Role of a Cr (IV)-mediated Fenton-like reaction. Carcinogenesis 15: 2475–2478, 1994
Shi X, Dalal NS: The role of superoxide radical in chromium (VI)-generated hydroxyl radical: The Cr (VI) Haber-Weiss cycle. Arch Biochem Biophys 292: 323–327, 1992
Liu KJ, Jiang J, Swartz HM, Shi X. Low-frequency EPR detection of chromium (V) formation by chromium (VI) reduction in whole live mice. Arch Biochem Biophys 313: 248–252, 1994
Liu KJ, Shi X, Jiang JJ, Goda F, Dalal N, Swartz HM: Chromate-induced chromium (V) formation in live mice and its control by cellular antioxidants: An L-band electron paramagnetic resonance study. Arch Biochem Biophys 323: 33–9, 1995
Yuann JM, Liu KJ, Hamilton JW, Wetterhahn KE: In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium (V), chromium-DNA binding and 8-hydroxy-2′-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium (VI). Carcinogenesis 20: 1267–1275, 1999
Tandon SK, Behari JR, Kachru DN: Distribution of chromium in poisoned rats. Toxicology 13: 29–34, 1979
Liu KJ, Mader K, Shi X, Swartz HM: Reduction of carcinogenic chromium (VI) on the skin of living rats. Mag Res Med 38: 524–526, 1997
Dalal NS, Suryan MM, Seehra MS: Potassium perchromate standard for determination of paramagnetic spin concentration, g values, and magnetic moments of fossil fuels. Anal Chem 53: 938–940, 1981
Liebross RH, Wetterhahn KE: In vivo formation of chromium (V) in chick embryo liver and red blood cells. Carcinogenesis 13: 2113–2120, 1992
Fujii H, Wan X, Zhong J, Berliner LJ, Yoshikawa K: In vivo imaging of spin-trapped nitric oxide in rats with septic shock: MRI spin trapping. Mag Res Med 42: 235–239, 1999
Ueno S, Susa N, Furukawa Y, Sugiyama M: Formation of paramagnetic chromium in liver of mice treated with dichromate (VI). Toxicol Appl Pharmacol 135: 165–171, 1995
Sugiyama M, Tsuzuki K: Effect of glutathione depletion on formation of paramagnetic chromium in Chinese hamster V-79 cells. FEBS Lett 341: 273–276, 1994
Stearns DM, Kennedy LJ, Courtney KD, Giangrande PH, Phieffer LS, Wetterhahn KE: Reduction of chromium (VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 34: 910–919, 1995
Rossi SC, Gorman N, Wetterhahn KE: Mitochondrial reduction of the carcinogen chromate: Formation of Cr (V), Chem Res Toxicol 1: 101–107, 1988
Micera G, Dessi A: Chromium adsorption by plant roots and formation of long-lived Cr (V) species: An ecological hazard? J Inorg Biochem 34: 157–166, 1988
Mao Y, Zang L, Shi X: Generation of free radicals by Cr (IV) from lipid hydroperoxides and its inhibition by chelators. Biochem Mol Biol Int 36: 327–337, 1995
Faux SP, Gao M, Chipman JK, Levy LS: Production of 8-hydroxydeoxyguanosine in isolated DNA by chromium (VI) and chromium (V). Carcinogenesis 13: 1667–1669, 1992
Barr-David G, Charara M, Codd R, Farrell R, Irwin J, Lay P, Bramley R, Brumby S, Ji JY, Hanson G: EPR characterization of the Cr (V) intermediates in the Cr (V/VI) oxidations of organic substrates and of relevance to Cr-induced cancers. J Chem Soc Faraday Trans 91: 1207–1216, 1995
Shi X, Dong Z, Huang C, Ma W, Liu K, Ye J, Chen F, Leonard SS, Ding M, Castranova V, Vallyathan V: The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappa B. Mol Cell Biochem 194: 63–70, 1999
Shi X, Ding M, Ye J, Wang S, Leonard SS, Zang L, Castranova V, Vallyathan V, Chiu A, Dalal N, Liu K: Cr (IV) causes activation of nuclear transcription factor-kappa B, DNA strand breaks and dG hydroxylation via free radical reactions. J Inorg Biochem 75: 37–44, 1999
Sugiyama M: Role of cellular antioxidants in metal-induced damage. Cell Biol Toxicol 10: 1–22, 1994
Standeven AM, Wetterhahn KE: Ascorbate is the principal reductant of chromium (VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis 13: 1319–1324, 1992
Moghaddas S, Gelerinter E, Bose RN: Mechanisms of formation and decomposition of hypervalent chromium metabolites in the glutathione-chromium (VI) reaction. J Inorg Biochem 57: 135–146, 1995
Gannett PM, Dalal NS, Shi XL, Toth B: 8-Hydroxy-2′-deoxyguanosine formation during the catalytic oxidation of hydrazines in the presence of 2′-deoxyguanosine. Chem Biol Interact 80: 57–72, 1991
Shi XL, Dalal NS: NADPH-dependent flavoenzymes catalyze one electron reduction of metal ions and molecular oxygen and generate hydroxyl radicals. FEBS Lett 276: 189–91, 1990
Liu KJ, Shi X, Jiang J, Goda F, Dalal N, Swartz HM: Low frequency electron paramagnetic resonance investigation on metabolism of chromium (VI) by whole live mice. Ann Clinical Lab Sci 26: 176–184, 1996
Shi XL, Dalal NS: Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem Biophys Res Commun 163: 627–634, 1989
Ueno S, Sugiyama M, Susa N, Furukawa Y: Effect of dimethylthiourea on chromium (VI)-induced DNA single-strand breaks in Chinese hamster V-79 cells. Mutat Res 346: 247–253, 1995
Sugiyama M, Tsuzuki K, Haramaki N: Influence of o-phenanthroline on DNA single-strand breaks, alkali-labile sites, glutathione reductase, and formation of chromium (V) in Chinese hamster V-79 cells treated with sodium chromate (VI). Arch Biochem Biophys 305: 261–266, 1993
Sugiyama M: Role of physiological antioxidants in chromium (VI)-induced cellular injury. Free Rad Biol Med 12: 397–407, 1992
Sugiyama M: Effects of vitamins on chromium (VI)-induced damage. Environ Health Perspect 92: 63–70, 1991
Kawanishi S, Inoue S, Yamamoto K: Active oxygen species in DNA damage induced by carcinogenic metal compounds. Environ Health Perspect 102(suppl 3): 17–20, 1994
Kadiiska MB, Xiang QH, Mason RP: In vivo free radical generation by chromium (VI): An electron spin resonance spin-trapping investigation. Chem Res Toxicol 7: 800–805, 1994
Aiyar J, Berkovits HJ, Floyd RA, Wetterhahn KE: Reaction of chromium (VI) with glutathione or with hydrogen peroxide: Identification of reactive intermediates and their role in chromium (VI)-induced DNA damage. Environ Health Perspect 92: 53–62, 1991
Aiyar J, Berkovits HJ, Floyd RA, Wetterhahn KE: Reaction of chromium (VI) with hydrogen peroxide in the presence of glutathione: Reactive intermediates and resulting DNA damage. Chem Res Toxicol 3: 595–603, 1990
Bagchi D, Hassoun EA, Bagchi M, Stohs SJ: Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 110: 177–187, 1995
Sugiyama M, Lin XH, Costa M: Protective effect of vitamin E against chromosomal aberrations and mutation induced by sodium chromate in Chinese hamster V79 cells. Mutat Res 260: 19–23, 1991
Tsuzuki K, Sugiyama M, Haramaki N: DNA single-strand breaks and cytotoxicity induced by chromate (VI), cadmium (II), and mercury (II) in hydrogen peroxide-resistant cell lines. Environ Health Perspect 102(suppl 3): 341–342, 1994
Chen F, Ding M, Lu Y, Leonard SS, Vallyathan V, Castranova V, Shi X: Participation of MAP kinase p38 and I-kappaB kinase in chromium (VI)-induced NF-kappaB and AP-1 activation. J Environ Pathol Toxicol Oncol 19: 231–238, 2000
Wang S, Leonard SS, Ye J, Ding M, Shi X: The role of hydroxyl radical as a messenger in Cr (VI)-induced p53 activation. Am J Physiol - Cell Physiol 279: C868–C875, 2000
Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonini J, Ding M, Rojanasakul Y, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and p53 in chromium (VI)-induced apoptosis. J Biol Chem 274: 34974–34980, 1999
Ye J, Zhang X, Young HA, Mao Y, Shi X: Chromium (VI)-induced nuclear factor-kappa B activation in intact cells via free radical reactions. Carcinogenesis 16: 2401–2405, 1995
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, K., Shi, X. In vivo reduction of chromium (VI) and its related free radical generation. Mol Cell Biochem 222, 41–47 (2001). https://doi.org/10.1023/A:1017994720562
Issue Date:
DOI: https://doi.org/10.1023/A:1017994720562